Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2020 Results

Go back to Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2020 Results

Thermo Fisher Scientific (TMO) PT Raised to $585 at Cowen

February 1, 2021 6:07 PM EST

Cowen analyst Doug Schenkel raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $585.00 (from $525.00) while maintaining an Outperform rating.

The analyst commented, "COVID-19 drove another revenue & EPS beat in Q4. Encouragingly, the base business returned to ~MSD growth. 2021 guidance is... More

Thermo Fisher Scientific (TMO) Tops Q4 EPS by 80c

February 1, 2021 6:22 AM EST

Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $7.09, $0.80 better than the analyst estimate of $6.29. Revenue for the quarter came in at $10.55 billion versus the consensus estimate of $9.3 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.

... More